HEC-6Homo sapiens (Human)Cancer cell line

Also known as: HEC6

🤖 AI SummaryBased on 7 publications

Quick Overview

Human endometrial cancer cell line with pseudo-diploid karyotype and adenocarcinoma features.

Detailed Summary

HEC-6 is a human endometrial cancer cell line established from an adenoacanthoma, showing characteristics of well-differentiated adenocarcinoma. It exhibits a pseudo-diploid karyotype with random chromosomal variations and forms glandular structures in culture. The cell line maintains the original tumor's features, including both epithelial and squamous components, and is transplantable in vivo. HEC-6 demonstrates a population doubling time of 52 hours and is used for studying endometrial cancer biology and therapeutic responses.

Key Characteristics

Pseudo-diploid karyotypeGlandular structure formation in cultureTransplantable in vivoMaintains original tumor features
Generated on 6/19/2025

Basic Information

Database IDCVCL_2931
SpeciesHomo sapiens (Human)
Tissue SourceEndometrium[UBERON:UBERON_0001295]

Donor Information

Age48
Age CategoryAdult
SexFemale
Raceasian

Disease Information

DiseaseEndometrial endometrioid adenocarcinoma, variant with squamous differentiation
LineageUterus
SubtypeUterine Adenosquamous Carcinoma
OncoTree CodeUASC

DepMap Information

Source TypeHSRRB
Source IDACH-000984_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg273His (c.818G>A)Homozygous-Unknown, PubMed=16264262
MutationSimplePTENp.Glu288fs*3 (c.863delA)Heterozygous-Unknown
MutationSimpleKRASp.Val160Ala (c.479T>C)Heterozygous-Unknown
MutationSimplePIK3CAp.Cys420_Pro421del (c.1258_1263delTGTCCA)Heterozygous-Unknown
MutationSimplePIK3CAp.Arg108His (c.323G>A)Heterozygous-Unknown
MutationSimpleCTNNB1p.Asp32Val (c.95A>T)Heterozygous-Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
9,10,13
D13S317
11,12
D16S539
8,10
D18S51
12,13
D19S433
14
D21S11
27.2,29
D2S1338
21,23
D3S1358
16,17
D5S818
13,14,15
D7S820
8,9,11,12
D8S1179
9,10,12
FGA
20,21,22
Penta D
10
Penta E
14,15,17
TH01
6,9,10
TPOX
8,9,10
vWA
16,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Quantitative study on the correlation between p53 gene mutation and its expression in endometrial carcinoma cell lines.

Kamata Y., Watanabe J., Hata H., Hamano M., Kuramoto H.

Eur. J. Gynaecol. Oncol. 25:55-60(2004).

In vitro effects of gonadotropin-releasing hormone (GnRH) analogue on cancer cell sensitivity to cis-platinum.

Ohta H., Sakamoto H., Satoh K.

Cancer Lett. 134:111-118(1998).

Establishment and characterization of human endometrial cancer cell lines.

Ohno E., Iida T.

Ann. N. Y. Acad. Sci. 622:402-421(1991).

Establishment and characterization of the cell-line of a human endometrial adenoacanthoma.

Kuramoto H., Hamano M.

Eur. J. Cancer 13:253-259(1977).

HEC-1 cells: establishment of an in vitro experimental system in endometrial carcinoma.

Kawaguchi M.

(In book chapter) Cell and molecular biology of endometrial carcinoma; Kuramoto H., Nishida M. (eds.); pp.3-34; Springer; Tokyo; Japan (2003).

Web Resources